International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:International Drug Development Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9328
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical services comprise study design, clinical development strategy, biostatistical analysis, interim analysis, biomarker validation and medical writing, among others. IDDI’s risk-based monitoring services include risk indicator and central statistical monitoring. The institute offers clinical research services in therapeutic areas of cancer research, ophthalmology, rare diseases and biosimilars. It caters to pharmaceutical companies, biotechs, start-ups, academic groups and CROs. IDDI is headquartered in Louvain-la-Neuve, Belgium.

International Drug Development Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Drug Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International Drug Development Institute, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
International Drug Development Institute Partners with Ophthotech 10
International Drug Development Institute Partners with Oraya Therapeutics 11
International Drug Development Institute Partners with Exonhit 12
International Drug Development Institute – Key Competitors 13
International Drug Development Institute – Key Employees 14
International Drug Development Institute – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
International Drug Development Institute, Pharmaceuticals & Healthcare, Key Facts 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Drug Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Drug Development Institute, Deals By Therapy Area, 2012 to YTD 2018 8
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International Drug Development Institute Partners with Ophthotech 10
International Drug Development Institute Partners with Oraya Therapeutics 11
International Drug Development Institute Partners with Exonhit 12
International Drug Development Institute, Key Competitors 13
International Drug Development Institute, Key Employees 14
International Drug Development Institute, Subsidiaries 15

List of Figures
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Institute on Drug Abuse-製薬・医療分野:企業M&A・提携分析
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • Cracker Barrel Old Country Store, Inc.:企業の戦略・SWOT・財務分析
    Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Northeastern Rural Electric Membership Corp:企業の戦略的SWOT分析
    Northeastern Rural Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Centice Corporation-医療機器分野:企業M&A・提携分析
    Summary Centice Corporation (Centice) is a medical and electronic equipment company which designs, develops and offers advance sensors for various applications. The company’s products include BTL-200N, MFL-300N, BTL-200P, MFL-300P, and MFL-3000. It also provides illicit substances, prescription drug …
  • Taisho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products that include lipovitan D, riup, clari …
  • Taita Chemical Co Ltd (1309):企業の財務・戦略的SWOT分析
    Taita Chemical Co Ltd (1309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Square Inc:企業のM&A・事業提携・投資動向
    Square Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Square Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • SolarCity Corporation-エネルギー分野:企業M&A・提携分析
    Summary SolarCity Corporation (SolarCity), a subsidiary of Tesla, Inc., is a vertically integrated solar energy systems provider that designs, permits, finances, and installs the solar energy and storage systems,. The company also performs maintenance and monitoring services. It procures various com …
  • SOHO Global Health:企業の戦略的SWOT分析
    SOHO Global Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • ISS AS:企業のM&A・事業提携・投資動向
    ISS AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ISS AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • KCOM Group PLC (KCOM):企業の財務・戦略的SWOT分析
    Summary KCOM Group PLC (KCOM) is a technology company that provides communication and information technology services. The company provides IT and integration services, including cloud-based infrastructure and contact and collaboration solutions. It offers broadband and telephony services for consum …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) is a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers water se …
  • Ascendance Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company’s products include human HepatoMune kits, HepatoPac B-CLEAR transporter kits, human HepatoPac kits, rat HepatoPac kits, monkey HepatoPac kits …
  • Serum Institute of India Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Serum Institute of India Ltd (Serum Institute) is a biotechnology company that manufactures and markets vaccines and immuno-biologicals. The company offers products such as bacterial vaccines, viral vaccines, recombinant and combination vaccines, polysaccharide conjugate vaccines, meningococ …
  • Nevro Corp (NVRO):医療機器:M&Aディール及び事業提携情報
    Summary Nevro Corp (Nevro) is a medical device company that offers products for the treatment of chronic pain. The company develops and commercializes senza spinal cord stimulation system (SCS), an evidence-based neuromodulation platform. Its solution for chronic pain also includes HF10 Therapy, whi …
  • Cold Spring Harbor Laboratory:製薬・医療:M&Aディール及び事業提携情報
    Summary Cold Spring Harbor Laboratory (CSHL) is a research and education institution that offers molecular biology and genetics services. The institution offers research services such as graduate research, research training, clinical research, quantitative biology research, postdoctoral research, di …
  • Mahindra & Mahindra Financial Services Limited:企業のM&A・事業提携・投資動向
    Mahindra & Mahindra Financial Services Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mahindra & Mahindra Financial Services Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descriptio …
  • NuGEN Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company offers DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DNA …
  • Activision Blizzard Inc (ATVI):企業の財務・戦略的SWOT分析
    Activision Blizzard Inc (ATVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Bharat Sanchar Nigam Ltd:企業の戦略的SWOT分析
    Bharat Sanchar Nigam Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆